Monarch Partners Asset Management LLC Phathom Pharmaceuticals, Inc. Transaction History

Monarch Partners Asset Management LLC

  • $328 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021
SELL
$33.22 - $50.26 $708,416 - $1.07 Million
-21,325 Closed
0 $0
Q3 2020

Nov 05, 2020
SELL
$29.24 - $40.19 $11,783 - $16,196
-403 Reduced 1.85%
21,325 $782,000
Q2 2020

Jul 31, 2020
BUY
$25.06 - $54.6 $544,503 - $1.19 Million
21,728 New
21,728 $715,000

Others Institutions Holding PHAT

# of Institutions
144
Shares Held
73.6M
Call Options Held
42.3K
Put Options Held
45.7K
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $351M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email